Anti-TNFa therapy in patients with rheumatoid arthritis decreased cytokines and acute phase proteins including IL-6, IL-1 receptor antagonist, serum amyloid A, haptoglobin, and fibrinogen [73,74,75]. Here, IL6 is linked to rheumatoid arthritis.